Last updated 47 days ago
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
337 patients around the world
Available in Argentina, Mexico, United States
Pfizer
10Research sites
337Patients around the world
This study is for people with
Prostate cancer
Metastatic prostate cancer
Breast Cancer
Liposarcoma
Dedifferentiated Liposarcoma
Solid tumors
Lung cancer
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Sites
Centro de Investigaciones Clínicas - Clínica Viedma - Río Negro
Recruiting
Fundación Cori para la Investigación y Prevención del Cáncer - La Rioja
Recruiting
Fundación CENIT para la Investigación en Neurociencias
Recruiting
Fundación Respirar
Recruiting
Incan - Instituto Do Cancer - Hospital Pompeia
Universidad Autónoma de Nuevo León, Hospital Universitario Dr. José Eleuterio González
Recruiting
Oaxaca Site Management Organization S.C.
Recruiting
Hospital MAC - Periférico Sur
Recruiting
COI Centro Oncológico Internacional S.A.P.I
Recruiting
Hospital Reforma
Recruiting
StudyCDK4i
SponsorPfizer
Study typeInterventional
Conditions
Metastatic prostate cancerBreast CancerDedifferentiated LiposarcomaSolid tumorsLung cancer
Requirements
From 18 YearsAll Gender
Unique study IDclinicaltrials.gov
NCT04557449
